US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 17:28:58 Source：Global Grid news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：NBA playoffs: Edwards leads Wolves to 98
- Next：What's next for Iran after death of its president in crash?
Related articles
- Britain's new bonkers EV: Callum Skye is an £80k electric buggy built in Warwickshire
- Who will receive Meghan's top 5 jams? As the Duchess's A
- Anthony Edwards scores 36 points, Timberwolves beat Suns 126
- Video surfaces of 326
- Target to lower prices on basic goods in response to inflation
- Olympic champion Gabby Douglas competes at the American Classic
- Simbine upstages Coleman and Kerley to win 100
- The tunnels have EYES! Inside the hidden 100
- Iran helicopter crash that killed President Raisi could reverberate across the Middle East
- Katie Price's Mucky Mansion is surrounded by her huge car collection
- Investigators return to Long Island home of Gilgo Beach serial killing suspect
- Rihanna puts on a VERY busty display in a sexy sand
- Commanders get their QB in Jayden Daniels, fill several holes in the NFL draft
- Miserable runs continue for Juventus and injury
- Amtrak train hits pickup truck in upstate New York, 3 dead including child
- Who will receive Meghan's top 5 jams? As the Duchess's A
- Lightning D Sergachev is surprise addition to roster for must
- Haliburton breaks tie with 3
- Kevin Pillar gets 1,000th career hit in Angels' win at Texas
- Olly Murs shares he's juggling nappies and late nights as he gives insight into fatherhood while on
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Global Grid news portal sitemap